PTEN methylation involved in benzene-induced hematotoxicity

Area of Science:

• Toxicology
• Epigenetics
• Molecular Biology

Background:

• Benzene is a known hematotoxic carcinogen.
• PTEN (Phosphatase and Tensin homolog) is a critical tumor suppressor gene.
• PTEN promoter methylation leads to transcriptional silencing, but its role in benzene toxicity was unclear.

Purpose of the Study:

• To investigate the effect of PTEN promoter methylation on benzene-induced hematotoxicity.
• To elucidate the mechanism by which benzene affects PTEN expression and methylation.

Main Methods:

• Established an animal model for benzene-induced hematotoxicity.
• Administered varying doses of benzene to rats and analyzed white blood cell counts and body weight.
• Quantified PTEN promoter methylation levels and PTEN mRNA expression in vivo and in vitro (lymphoblast cell line F32).
• Utilized epigenetic inhibitors (5-aza and TSA) to assess their impact on PTEN methylation and expression.

Main Results:

• Benzene exposure significantly decreased white blood cell counts and altered body weight in a dose-dependent manner.
• PTEN promoter methylation increased significantly with increasing benzene doses.
• PTEN mRNA expression initially increased at low benzene doses but decreased at higher doses.
• Benzene treatment of lymphoblast cells mirrored these findings, showing increased PTEN methylation and decreased mRNA expression.
• Epigenetic inhibitors reversed these effects, reducing PTEN methylation and increasing mRNA expression.

Conclusions:

• PTEN promoter methylation is significantly involved in benzene-induced hematotoxicity.
• Benzene suppresses PTEN mRNA expression through epigenetic mechanisms, leading to decreased tumor suppressor function.
• This study identifies PTEN methylation as a key molecular event in benzene's toxic effects on the hematopoietic system.